Automata Company Profile: Funding, Investors, LINQ Platform and Leadership
Updated: 7 days ago
Automata is a London company that automates life science laboratories with LINQ, a platform that combines modular robotics and orchestration software. In January 2026 it announced a Series C of USD 45 million, with Danaher as a strategic investor. This profile sets out its funding, investors, platform and leadership.
Automata at a Glance
Fact | Detail |
Company | Automata |
Headquarters | London, United Kingdom |
Product | LINQ lab automation platform |
Latest funding | Series C of USD 45 million, announced January 29, 2026 |
Lead investor | Dimension |
Strategic investor | Danaher |
Customers | Five top pharmaceutical companies, according to the company |
Stock listing | None; privately held |
Chief Executive Officer | Mostafa Elsayed |
The 2026 Series C
Item | Detail |
Amount | USD 45 million |
Lead | Dimension |
Other investors | Danaher Ventures, Tru Arrow Partners, Octopus Ventures and Entrepreneurs First |
Board addition | Murali Venkatesan, global head of Danaher Ventures |
Danaher's involvement is also a partnership: its companies Molecular Devices and Beckman Coulter Life Sciences will integrate Automata's software into liquid handling, genomic and cell analysis workflows.
The company plans to use the money to scale customer deployments worldwide, build software for closed-loop experimentation and expand its engineering, product and customer teams.
The LINQ Platform
LINQ pairs modular robotic hardware with software that orchestrates the instruments in a laboratory. The chief executive describes it as an operating layer between AI models and the physical lab, meaning that experiments designed by software can be run automatically and their results fed back.
Automata product reviews on All Things Cobots
Leadership
Name | Role |
Mostafa Elsayed | Chief Executive Officer |
Can You Invest in Automata?
Not on a public market. Automata is privately held.
Strengths and Challenges
Strengths
Repeat deployments at large pharmaceutical companies.
A strategic partner in Danaher, whose instruments are widely used in labs.
A product positioned for AI-driven research.
Challenges
A specialized market with long sales cycles.
No published revenue figures.
Current Catalogue Coverage
Catalogue checked on 15 October 2026: 2 associated product records. The links below are representative entries, rather than a claim that every historical model is currently available.
Automata FAQ
What does Automata do?
It automates life science laboratories with its LINQ platform of modular robotics and orchestration software.
Where is Automata based?
In London.
How much did Automata raise in 2026?
USD 45 million in a Series C led by Dimension.
What is Danaher's role?
Danaher is a strategic investor and partner; its Molecular Devices and Beckman Coulter Life Sciences businesses will integrate Automata's software.
Who is the CEO of Automata?
Mostafa Elsayed.
Sources
R&D World: Automata raises USD 45 million
